Desferal (desferrioxamine)-A novel activator of connective tissue-type mast cells

The Journal of Allergy and Clinical Immunology

Volumn 88, Issue 6, 1991, Pages 854-860

  Shalit, Meir ^a   Tedeschi, Alberto ^a   Miadonna, Antonio ^a   Levi Schaffer, Franceses ^a  

^a NONE

Author keywords

Desferal; histamine release; mast cell; skin

Indexed keywords

CETIRIZINE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ARTICLE; DRUG HYPERSENSITIVITY; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTRADERMAL DRUG ADMINISTRATION; MALE; MAST CELL; MOUSE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SKIN TEST;

ANIMAL; BASOPHILS; BONE MARROW CELLS; CONNECTIVE TISSUE; CONNECTIVE TISSUE CELLS; DEFEROXAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HISTAMINE RELEASE; HUMAN; MALE; MAST CELLS; MICE; PERITONEAL CAVITY; RATS; SKIN; SKIN TESTS;

EID: 0026356316     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(91)90241-F     Document Type: Article

References (24)

1. Lens opacities in thalassemia
2. Ocular toxicity of high-dose intravenous desferrioxamine
3. Anaphylactic reaction to desferrioxamine
4. Rapid desensitisation for desferrioxamine anaphylactic reaction
5. Rapid desensitisation for desferrioxamine anaphylactoid reactions
6. Studies on the mechanisms of hypersensitivity phenomena
7. Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro
8. Interleukin-3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan
9. Increased sensitivity of the enzymatic isotopic assay of histamine: measurement of histamine in plasma and serum
10. New role for heparan sulfate: regulator of leukotriene generation in mouse E mast cells
11. Membrane events in the triggering of mast cells
12. Agents that release histamine from mast cells
13. Characteristics of histamine secretion induced by neuropeptides: implications for the relevance of peptide-mast cell interactions in allergy and inflammation
14. Drug allergy
15. Histamine release from isolated rat mast cells: effect of morphine and related drugs and their interaction with compound 48/80
16. Immediate hypersensitivity reactions to penicillin and related antibiotics
17. Does non-immunologic mast cell mediator release elicit a late cutaneous response?
18. Induction of human cutaneous mast cell degranulation by opiates and endogenous opoid peptides: evidence for opiate and nonopiate receptor participation
19. Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells
20. Factors which influence late cutaneous allergic responses
21. 2 in rat peritoneal mast cells activated with peptides
22. Mediator release from human skin mast cells: differences between IgE-dependent and non-immunological stimuli
23. Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli
24. Mast cell heterogeneity